Last checked at 
LONDON (Alliance News) - Tissue Regenix Group PLC said Monday it expects annual revenue to rise by 47% on the back of strong customer demand across all its brands.
For 2018, the company said it expects revenue of GBP11.6 million, up from GBP7.9 million a year ago.
DermaPure revenue grew 79% on a constant currency basis to GBP3.4 million, and Orthopaedics & Dental revenue grew by 31% to GBP6.4 million, while the firm's joint venture GBM-v delivered sales of GBP1.8 million.
Tissue Regenix shares were trading up 5.4% at 6.06 pence each.
